MENVEO subst sèche c solv flac
7680625020015
CH-62502
J07AH08
08.08.
Reimbursement limitations:
0808 NEU
La prise en charge des coûts des vaccins au titre de mesure préventive dans le …
1 / 3
google
Details
- Product number
- 6250201
- CPT
- -
- Packaging group
- 1
- Unit
- Kombipackung(en)
- Composition
- I) Vaccinum conjugatum in praeparatio cryodesiccata: oligosaccharida neisseriae meningitidis A 10 µg conjugatum cum proteinum corynebacteriae diphtheriae CRM 197 16.7-33.3 µg, kalii dihydrogenophosphas corresp. kalium 0.098 mg, saccharum, pro vitro. . II) Vaccini conjugati in solutio: oligosaccharida neisseriae meningitidis C 5 µg conjugatum cum proteinum corynebacteriae diphtheriae CRM 197 7.1-12.5 µg, oligosaccharida neisseriae meningitidis W-135 5 µg conjugatum cum proteinum corynebacteriae diphtheriae CRM 197 3.3-8.3 µg, oligosaccharida neisseriae meningitidis Y 5 µg conjugatum cum proteinum corynebacteriae diphtheriae CRM 197 5.6-10 µg, natrii chloridum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas dihydricus, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.885 mg.
Articles (1)
Menveo, Pulver und Lösung (Durchstechflaschen)
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
I
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
II
|
5.0 UG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
I
|
- | Substance | WIZUS |
|
II
|
5.0 UG | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | WIZUS |
|
I
|
0.098 MG | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
II
|
5.0 UG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
1.885 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 50.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2012
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 62502
- Drug name
- Menveo, Pulver und Lösung (Durchstechflaschen)
- Galenic form
- SUPA
- ATC Code
- J07AH08
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 30/11/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MENVEO subst sèche c solv flac
- Description (DE)
- MENVEO Trockensub c Solv Durchstf
- Market launch
- 30/11/2011
- Narcotic (BTM)
- No